OncoTargets and Therapy
Volume 10, 2017 - Issue
Open access
52
Views
17
CrossRef citations to date
0
Altmetric
Original Research
Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma
Antonio Miguel1 Department of Pharmacology, Faculty of Medicine, University of Valencia
, Luis Sendra1 Department of Pharmacology, Faculty of Medicine, University of Valencia
, Verónica Noé2 Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, University of Barcelona
, Carles J Ciudad2 Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, University of Barcelona
, Francisco Dasí3 Research University Hospital of Valencia, INCLIVA Health Research Institute;4 Department of Physiology, Faculty of Medicine, University of Valencia Foundation
, David Hervas5 Biostatistics Unit
, María José Herrero1 Department of Pharmacology, Faculty of Medicine, University of Valencia;6 Pharmacogenetics Unit, Instituto de Investigación Sanitaria La Fe (IIS La Fe)Correspondence[email protected]
& Salvador F Aliño1 Department of Pharmacology, Faculty of Medicine, University of Valencia;7 Clinical Pharmacology Unit, ACM Hospital Universitario y Politécnico La Fe, Valencia, Spain
show all
Pages 503-514
|
Published online: 23 Jan 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.